Genomma Lab Internacional SAB de CV

GEKA

Company Profile

  • Business description

    Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

  • Contact

    Avenida Antonio Dovali Jaime, Number 70
    Tower C, Floor 2, Office A. Colonia Santa Fe
    Del. Alvaro Obregon
    MexicoMEXCP 01210
    MEX

    T: +52 50810000

    https://www.genommalab.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,975

Stocks News & Analysis

stocks

What next for the largest company on the ASX?

After a historic rally in 2024, what lies ahead for this overvalued banking titan?
stocks

Ask the analyst: Are IDP Education's woes temporary?

The global education services provider has gone from stock market darling to one of the ASX's weakest performers. What gives?
stocks

Is it time to buy the Magnificent Seven?

After the recent selloff, the bull market’s most in-demand stocks look much cheaper.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,013.3046.700.59%
CAC 408,028.2890.071.13%
DAX 4022,986.82419.681.86%
Dow JONES (US)41,488.19674.621.65%
FTSE 1008,632.3389.771.05%
HKSE23,959.98497.332.12%
NASDAQ17,754.09451.072.61%
Nikkei 22537,053.10263.070.72%
NZX 50 Index12,266.2557.200.47%
S&P 5005,638.94117.422.13%
S&P/ASX 2007,789.7040.600.52%
SSE Composite Index3,419.5660.831.81%

Market Movers